Ocular immunosuppressive microenvironment

Chemical Immunology

Volumn 73, Issue , 1999, Pages 72-89

  Taylor, Andrew W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE;

AQUEOUS HUMOR; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; EYE; HUMAN; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0032877698     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058738     Document Type: Review

References (30)

1. Jorgensen JL, Reay PA, Ehrich EW, Davis MM: Molecular components of T-cell recognition. Annu Rev Immunol 1992;10:835-873.
2. Cher DJ, Mosmann TR: Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987;138:3688-3694.
3. Chen H, Hendricks RL: B7 costimulatory requirements of T cells at an inflammatory site. J Immunol 1998;160:5045-5052.
4. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor family. Immunol Today 1994;15:321-331.
5. Liu Y, Linsley PS: Costimulation of T-cell growth. Curr Opin Immunol 1992;4:265-270.
6. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
7. Dutton RW, Bradley LM, Swain SL: T cell memory. Annu Rev Immunol 1998;16:201-223.
8. Mosmann TR, Sad S: The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-146.
9. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper cell clones. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987;166:1229-1244.
10. Rook GA, Stanford JL: Give us this day our daily germs. Immunol Today 1998;19:113-116.
11. DeKruyff RH, Fang Y, Umetsu DT: IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. J Immunol 1992;149:3468-3476.
12. Weiner HL: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-343.
13. VanParijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998;280:243-248.
14. Li H, Ren J, Dhabuwala CB, Shichi H: Immunotolerancc induced by intratesticular antigen priming: Expression of TGF-β, Fas and Fas ligand. Ocul Immunol Inflamm 1997;5:75-84.
15. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
16. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-632.
17. Glickstein L, Macphail S, Stutman O: Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR. J Immunol 1996;156:2062-2067.
18. Hornung F, Zheng L, Lenardo MJ: Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J Immunol 1997;159:3816-3822.
19. Akbar AN, Salmon M: Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death. Immunol Today 1997;18:72-76.
20. Chen JJ, Sun Y, Nabel GJ: Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 1998;282:1714-1717.
21. De Maria R, Testi R: Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimunity. Immunol Today 1998;19:121-125.
22. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S: Reciprocal regulatory effects of INF-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992;148:2142-2147.
23. Taylor AW, Alard P, Yee DG, Streilein JW: Aqueous humor induces transforming growth factor-beta-producing regulatory T-cells. Curr Eye Res 1997;16:900-908.
24. Trinchieri G, Perussia B: Immune interferon: A pleiotropic lymphokine with multiple effects. Immunol Today 1985;6:131-136.
25. Farrar MA, Schreiber RD: The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993;11:571-611.
26. Yoneda Y, Yoshida R: The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site. J Immunol 1998;160:6012-6017.
27. Dvorak HF, Mihm MC Jr, Dvorak AM, Johnson RA, Manseau EJ, Morgan E, Colvin RB: Morphology of delayed-type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest 1974;31:111-130.
28. Dvorak AM, Mihm, MC Jr, Dvorak HF: Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest 1976;34:179-191.
29. Buchanan KL, Murphy JW: Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 1997;90:189-197.
30. Wangoo A, Cook HT, Taylor GM, Shaw RJ: Enhanced expression of type 1 procollagen and transforming growth factor-beta in tuberculin induced delayed type hypersensitivity. J Clin Pathol 1995;48:339-345.